3 ms·
> The downstream impact to disease and transmission risk, definitely not. In what way?
by djrogers 5y ago
> The downstream impact to disease and transmission risk, definitely not.
In what way?
- wpietri 5y agoIt will definitely not be better studied because it the focus and the funding is on how well vaccination works. Vaccines have a revenue model; natural immunity doesn't.